Rick Cote
Impact in
Papers in
-
- Retinal Development and Disorders 37
- Phosphodiesterase function and regulation 37
- Receptor Mechanisms and Signaling 15
- bioluminescence and chemiluminescence research 6
- Pharmacology 19
- Cholinesterase and Neurodegenerative Diseases 16
- Co-authors
- Eila Curlee Skinner (2 shared papers)Maged Mikhail (2 shared papers)John P. Stein (3 shared papers)Bernard H. Bochner (2 shared papers)Gary Lieskovsky (2 shared papers)An‐Chen Feng (2 shared papers)Susan G. Groshen (3 shared papers)Stuart D. Boyd (2 shared papers)
- Journals
- Journal of Biological Chemistry (20 papers)Journal of Molecular Biology (4 papers)Proceedings of the National Academy of Sciences (4 papers)The FASEB Journal (3 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Rick Cote
118 papers receiving 7.9k citations
Rick Cote's Hit Papers
Peers
Comparison fields: 5 of 160
- Urology 561
- Surgery 3.2k
- Cancer Research 545
- Molecular Biology 2.7k
- Oncology 978
Countries citing papers authored by Rick Cote
This map shows the geographic impact of Rick Cote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Cote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Cote more than expected).
Fields of papers citing papers by Rick Cote
This network shows the impact of papers produced by Rick Cote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Cote. The network helps show where Rick Cote may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Cote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients Hit paper breakdown → | 2001 | 2862 |
| 2 | Two molecular pathways to transitional cell carcinoma of the bladder. Hit paper breakdown → | 1994 | 521 |
| 3 | 2001 | 346 | |
| 4 | 1998 | 319 | |
| 5 | 2001 | 284 | |
| 6 | 2016 | 235 | |
| 7 | 1994 | 233 | |
| 8 | 2009 | 205 | |
| 9 | 2011 | 197 | |
| 10 | 2004 | 144 | |
| 11 | 2016 | 137 | |
| 12 | 1996 | 129 | |
| 13 | 1974 | 121 | |
| 14 | 2008 | 100 | |
| 15 | 2010 | 100 | |
| 16 | 1994 | 99 | |
| 17 | 2014 | 97 | |
| 18 | 2005 | 95 | |
| 19 | 1984 | 85 | |
| 20 | 2001 | 80 |
About Rick Cote
Rick Cote is a scholar working on Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience, Oncology and Plant Science, having authored 121 papers that have together received 8.3k indexed citations. Recurring topics across this work include Retinal Development and Disorders (37 papers), Phosphodiesterase function and regulation (37 papers), Cholinesterase and Neurodegenerative Diseases (16 papers), Receptor Mechanisms and Signaling (15 papers), Photoreceptor and optogenetics research (14 papers), Neurobiology and Insect Physiology Research (12 papers), bioluminescence and chemiluminescence research (6 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Urology (561 citations), Surgery (3.2k citations), Cancer Research (545 citations), Molecular Biology (2.7k citations) and Oncology (978 citations). Rick Cote has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Eila Curlee Skinner, Maged Mikhail, John P. Stein, Bernard H. Bochner, Gary Lieskovsky, An‐Chen Feng, Susan G. Groshen, Stuart D. Boyd, Derek Raghavan and Donald G. Skinner. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology, Proceedings of the National Academy of Sciences, The FASEB Journal and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.